GlaxoSmithKline plc and Alnylam Pharmaceuticals Inc. under a so-called "patent pool" are providing researchers free access to intellectual property, discovered compounds, technologies and know-how in the pursuit to find new medicines for infectious and parasitic diseases affecting the world's poorest nations - the neglected diseases. (BioWorld Today) Read More
